Loading clinical trials…
Loading clinical trials…
Clinical trials · failure tracking
Oncology studies whose overall status is TERMINATED, WITHDRAWN or SUSPENDED on ClinicalTrials.gov, with the stop reason exactly as the registrant posted it. A category is attached only when an explicit keyword rule matches the text; CancerIndex never infers why a study stopped.
16,112 stopped studies · 89% state a reason
Over the 16,112 studies matching the cancer, status and year filters (the category filter does not change this chart). Each study is counted once, in the first matching category; greyed bars are studies whose text matched no rule or was empty.
Computedrules ci-stop-reasons-v1 · keyword matching only
A category is assigned when one of its keywords appears in the posted text (case-insensitive, whole words). Rules are tested in this order and the first match wins; every match is kept in the API (reasonMatches).
| NCT | Title | Phase | Status | First posted | Lead sponsor | Why stopped (as posted) | Category |
|---|---|---|---|---|---|---|---|
| NCT00127595 | Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract | Phase 2 | terminated | Aug 8, 2005 | Gustave Roussy, Cancer Campus, Grand Paris | not stated | Not stated |
| NCT00126243 | Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP)… | Phase 2 | terminated | Aug 3, 2005 | French National Agency for Research on AIDS and Viral Hepatitis | not stated | Not stated |
| NCT00023166 | Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas | Phase 1 | terminated | Aug 27, 2001 | Enzon Pharmaceuticals, Inc. | not stated | Not stated |
| NCT00033956 | Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2 | Phase 1 / Phase 2 | suspended | Apr 18, 2002 | MetaPhore Pharmaceuticals | not stated | Not stated |
| NCT00034333 | Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in… | Phase 2 / Phase 3 | terminated | Apr 26, 2002 | FeRx | not stated | Not stated |
| NCT00036517 | Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal… | Phase 1 / Phase 2 | terminated | May 13, 2002 | PhytoCeutica | not stated | Not stated |
| NCT00042497 | Immunotherapy With Autologous Dexosomes for Patients With Stage IV Melanoma | Phase 2 | suspended | Aug 1, 2002 | Anosys | not stated | Not stated |
| NCT00043459 | Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma. | Phase 2 | terminated | Aug 12, 2002 | Tularik | not stated | Not stated |
| NCT00044785 | Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid Tumors | Phase 1 | terminated | Sep 6, 2002 | Wellstat Therapeutics | not stated | Not stated |
| NCT00048529 | Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or… | Phase 2 | suspended | Nov 4, 2002 | Tularik | not stated | Not stated |
| NCT00057382 | T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma… | Phase 2 / Phase 3 | terminated | Apr 2, 2003 | Tularik | not stated | Not stated |
| NCT00064636 | Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced… | Phase 1 | terminated | Jul 11, 2003 | Millennium Pharmaceuticals, Inc. | not stated | Not stated |
Stop reasons are registrant-reported free text and are displayed verbatim (truncated; hover for the full text). Categories come from explicit keyword rules and are never inferred from the study design, sponsor or outcome; a study that stopped for several reasons is filed under the first rule that matched. A TERMINATED status does not imply a negative result.
Data updated 22 days agoSource updated Aug 24, 2005source: clinicaltrials